Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2011-02-14
2011-11-22
Mertz, Prema (Department: 1646)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S141100, C424S143100
Reexamination Certificate
active
08062634
ABSTRACT:
Provided are methods of treatment for skin disorders. In particular, treatment, the skin disorders are generally inflammatory skin disorders, including improper wound healing. Provided are methods of using of a cytokine molecule.
REFERENCES:
patent: 5530101 (1996-06-01), Queen et al.
patent: 6001357 (1999-12-01), Wong et al.
patent: 7332156 (2008-02-01), Bowman et al.
patent: WO 01/18051 (2001-03-01), None
patent: WO 01/85790 (2001-11-01), None
Aggarwal, Sudeepta, and Gurney, Austin L., “IL-17: prototype member of an emerging cytokine family”,J. Leukoc. Biol. 71:1-8; 2002.
Benson, J., et al. (Mar. 22, 2002)FASEB Journal16(5):A1045 abstract, “The role of IL-23 in experimental autoimmune encephalomyelitis”.
Bonifaz, Laura, et al., “Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+T Cell Tolerance”,J. Exp. Med., 196(12):1627-1638, Dec. 16, 2002.
Brok, et al., “Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti-IL-12p40 monoclonal antibody,”Journal of Immunology(Dec. 1, 2002) 169:6554-6563.
Calhoun, Jason H., et al., “Diabetic Foot Ulcers and Infections: Current Concepts”,Advances in Skin&Wound Care, pp. 31-45, Jan./Feb. 2002.
Chuntharapai et al. (1997)Methods in Enzymol. 288:15-27 “Generation of Monoclonal Antibodies to Chemokine Receptors”.
Cohen, I. Kelman, and MAST, Bruce A., “Models of Wound Healing”,The Journal of Trauma, 30(12 Supp.):S149-155, Dec. 1990.
Cooper, Andrea M., et al., “Mice Lacking Bioactive IL-12 Can Generate Protective Antigen-Specific Cellular Responses to Mycobacterial Infection Only if the IL-12 p40 Subunit Is Present”,The Journal of Immunology, 168:1322-1327, 2002.
Cordoba-Rodriguez, et al., “IL-23 and IL-27: new members of the growing family of IL-12 related cytokines with important implications for therapeutics,”Expert Opinion on Biological Therapy(Aug. 2003) 3(5):715-723.
Costa, et al., “Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit,”Journal of Immunology(Aug. 15, 2001) 167(4):2379-2387.
Da Costa, Ricardo Marques, et al., “Double-blind Randomized Placebo-controlled Trial of the Use of Granulocyte-Macrophage Colony-stimulating Factor in Chronic Leg Ulcers”,Am. J. Surg., 173:165-168, 1997.
Edde, Lynn, et al., “Lactoferrin protects neonatal rats from gut-related systemic infection”,Am. J. Physiol. Gastrointest Liver Physiol., 281:G1140-G1150, 2001.
Elkins, Karen L., et al., “In Vivo Clearance of an Intracellular Bacterium,Francisella tularensisLVS, Is Dependent on the p40 Subunit of Interleukin-12 (IL-12) but Not on IL-12 p70”,Infection and Immunity, 70(4):1936-1948, Apr. 2002.
Engelhardt, Eva, et al., “Chemokines IL-8, GROα, MCP-1 IP-10, and Mig Are Sequentially and Differentially Expressed During Phase-Specific Infiltration of Leukocyte Subsets in Human Wound Healing”,American Journal of Pathology, 153(6):1849-1860, Dec. 1998.
Gallucci, Randle M., et al., “Interleukin-6 Treatment Augments Cutaneous Wound Healing in Immunosuppressed Mice”,Journal of Interferon and Cytokine Research, 21:603-609, 2001.
Gillitzer, Reinard, and Goebeler, Matthias, “Chemokines in cutaneous wound healing”,Journal of Leukocyte Biology, 69:513-521, Apr. 2001.
Gottrup, Finn, et al., “Models for use in wound healing research: A survey focusing on in vitro and in vivo adult soft tissue”,Wound Repair and Regeneration, 8(2):83-96, 2000.
Grellner, Wolfgang, “Time-dependent immunohistochemical detection of proinflammatory cytokines (IL-1β, IL-6, TNF-α) in human skin wounds”,Forensic Science International, 130:90-96, 2002.
Hölscher, Christoph, et al., “A Protective and Agonistic Function of IL-12p40 in Mycobacterial Infection”,The Journal of Immunology, 167:6957-6966, 2001.
Khavari, P.A., et al., “Cutaneous gene transfer for skin and systemic diseases”,Journal of Internal Medicine, 252:1-10, 2002.
Kohler and Milstein (1975)Nature256:495-497 “Continuous cultures of fused cells secreting antibody of predefined specificity”.
Kraft, William a, et al., “Cutaneous Infection in Normal and Immunocompromised Mice”,Infection and Immunity, 52(3):707-713, Jun. 1986.
Lehmann, Jörg, et al., “IL-12p40-Dependent Agonistic Effects on the Development of Protective Innate and Adaptive Immunity AgainstSalmonellaEnteritidis”,The Journal of Immunology, 167:5304- 5315, 2001.
Liu, Wei, et al., “Gene Therapy of Scarring: A Lesson Learned from Fetal Scarless Wound Healing”,Yonsei Medical Journal, 42(6):634-645, 2001.
Maeyama, et al., “Attenuation of Bleomycin-induced pneumopathy in mice by monoclonal antibody to interleukin-12,”American Journal of Physiology, Lung Cellular and Molecular Physiology(Jun. 2001) 280(6)L1128-L1137.
Mikayama et al. (1993)Proc. Nat'l Acad. Sci.(USA) 90:10056 “Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor”.
Moulin, Veronique, et al., “Modulated Response to Cytokines of Human Wound Healing Myofibroblasts Compared to Dermal Fibroblasts”,Experimental Cell Research, 238:283-293, 1998.
Oppmann, Birgit, et al., “Novel p19 Protein Engages IL-12p40 to Form a Cytokine, IL-23, with Biological Activities Similar as Well as District from IL-12”,Immunity, 13:715-725, Nov. 2000.
Padigel, Udaikumar M., et al., “The Development of a Thi1-Type Response and Resistance toLeishmania majorInfection in the Absence of CD40-CD40L Costimulation”,The Journal of Immunology, 167:5874-5879, 2001.
Parham, Christi, et al., “A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R”,The Journal of Immunology, 168:5699-5708, 2002.
Parks, William C., et al., “matrilysin in Epithelial Repair and Defense”,Chest, 120(1):36S-41S, Jul. 2001 Supplement.
Payne, Wyatt G., et al, “Long-term outcome study of growth factor-treated pressure ulcers”,The American Journal of Surgery, 181:81-86, 2001.
Presky, et al. (1995)Res. Imunol. 146:439-445 “IL12 receptors and receptor antagonists”.
Schwentker, Ann, et al, “Nitric oxide and wound repair: role of cytokines?”,Nitric Oxide, 7:1-10, 2002.
Singer, Adam J., and Clark, Richard A.F., “Cutaneous Wound Healing”,The New England Journal of Medicine, 341(10):738-746, Sep. 2, 1999.
Schaffer, Christopher J., and Nanney, Lillian B., “Cell Biology of Wound Healing”,International Review of Cytology, 169:151-181, 1996.
Sugawara, Tadaki, et al., “Regulation and Role of Interleukin 6 in Wounded Human Epithelial Keratinocytes”,Cytokine, 15(6):328-336, Sep. 21, 2001.
Sullivan, Tory P., et al., “The pig as a model for human wound healing”,Wound Repair and Regeneration, 9(2):66-76, Mar.-Apr. 2001.
Supplementary Partial European Search Report dated May 18, 2007 in counterpart European Patent Application No. 03814312.9.
Voet et al. (1990)Biochemistry, at pp. 126-128 and 228-234.
Walter, Michael J., et al., “Interleukin 12 p40 Production by Barrier Epithelial Cells during Airway Inflammation”,Journal of Experimental Medicine, 193(3):339-351, Feb. 5, 2001.
Werner, S. and Grose, R., “Regulation of Wound Healing by Growth Factors and Cytokines”,Physiol. Rev., 83:835-870, 2003.
Wiekowski, Maria T., et al., “Ubiquitous Transgenic Expression of the IL-23 Subunit p19 Induces Multiorgan Inflammation, Runting, Infertility, and Premature Death”,The Journal of Immunology, 166:7563-7570, 2001.
Wilson, Carole L., et al., “Regulation of Intestinal ;
Bowman Edward P.
Chan Jason R.
Chen Shi-Juan
Churakova Tatyana
Cua Daniel J.
Bellomy Gregory R.
Mertz Prema
Schering Corporation
LandOfFree
Methods of treating cutaneous ulcers and grafts using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating cutaneous ulcers and grafts using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating cutaneous ulcers and grafts using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4253351